Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine (18F) Positron Emission Tomography/Computerized Tomography Imaging in the Staging of Biochemically Recurrent Prostate Cancer
about
Advances in medical imaging for the diagnosis and management of common genitourinary cancers.Therapy assessment in prostate cancer using choline and PSMA PET/CT.MRI combined with PET-CT of different tracers to improve the accuracy of glioma diagnosis: a systematic review and meta-analysis.Positron Emission Tomography Imaging of Prostate Cancer with Ga-68-Labeled Gastrin-Releasing Peptide Receptor Agonist BBN7-14 and Antagonist RM26.Bayesian penalised likelihood reconstruction (Q.Clear) of 18F-fluciclovine PET for imaging of recurrent prostate cancer: semi-quantitative and clinical evaluation.Molecular imaging of prostate cancer.Salvage Pelvic Lymph Node Dissection After Fluciclovine Positron Emission Tomography/Computed Tomography Detected Prostate Cancer Recurrence.Diagnostic Performance of 18F-Fluciclovine in Detection of Prostate Cancer Bone Metastases.Who benefits most from early salvage radiation therapy after prostatectomy?Role of PET imaging for biochemical recurrence following primary treatment for prostate cancerFluciclovine positron emission tomography in the setting of biochemical recurrence following local therapy of prostate cancerClinical implications of PET/CT in prostate cancer management
P2860
Q39307896-A8BF6865-4BC7-4E58-AF63-738825D78ED0Q39328036-2B6197CA-789B-4854-A977-36D976ED46A5Q47973107-0140838D-9B2C-48A8-8FAF-84A5DD0F1720Q48098858-A9807B83-C32B-42D4-9E5D-A225BEF9F238Q48304602-ABF9C8FC-CC25-4127-9644-27628F5A64C0Q52411549-9AE4AE17-CC5F-4A98-9F9A-3DB1515110EEQ52570993-EB99FA29-4082-40D8-A21C-9A53F0C0659AQ53682227-ED12B224-76C1-42FD-9289-3EA97AF2B352Q55259773-2D89F4AF-8779-414F-9748-28C3DA3495BFQ58562169-A6B5EC66-18B6-4B93-864F-21B900DC1455Q59137129-A11BB82A-9AB9-477F-867D-E27325196027Q59137133-CBE327F9-1822-4270-9C0C-1B32BD6C0332
P2860
Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine (18F) Positron Emission Tomography/Computerized Tomography Imaging in the Staging of Biochemically Recurrent Prostate Cancer
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Multisite Experience of the Sa ...... ally Recurrent Prostate Cancer
@en
Multisite Experience of the Sa ...... ally Recurrent Prostate Cancer
@nl
type
label
Multisite Experience of the Sa ...... ally Recurrent Prostate Cancer
@en
Multisite Experience of the Sa ...... ally Recurrent Prostate Cancer
@nl
prefLabel
Multisite Experience of the Sa ...... ally Recurrent Prostate Cancer
@en
Multisite Experience of the Sa ...... ally Recurrent Prostate Cancer
@nl
P2093
P2860
P50
P1476
Multisite Experience of the Sa ...... ally Recurrent Prostate Cancer
@en
P2093
Albert Chau
Cristina Nanni
Frode Willoch
Funmilayo I Tade
Heidi Sletten
Katrine Andersen Korsan
Lucia Zanoni
Mark M Goodman
Oluwaseun Odewole
P2860
P304
P356
10.1016/J.JURO.2016.09.117
P407
P433
P577
2016-10-13T00:00:00Z